Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
Status:
Unknown status
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
Prospective phase II study. Patients will be submitted to neoadjuvant chemotherapy (cT) and
hypo fractionated radiotherapy (hRT) following by surgery. The remain viable cells will be
analyzed and the patients whithin less than 30% will receive more 3 cycles of cT. All
patients have deep high grade soft tissue sarcoma of extremity.